Tolerability, safety and efficacy of Iloprost infusion without peristaltic pump in systemic sclerosis

• Autors principals: M. Arreghini (Autor), P. Prudente (Autor), W. Maglione (Autor), C. Arnoldi (Autor), S. Tosi (Autor), A. Marchesoni (Autor)
• Format: Llibre
• Publicat: PAGEPress Publications, 2001-06-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Objective. To evaluate safety, tolerability and efficacy on Raynaud's phenomenon (Rp) of iloprost infusion without peristaltic pump in patients with systemic sclerosis (SSc). Patients and methods. The inclusion criteria were diagnosis of SSc, age between 18 and 65 years, presence of Rp, and abs...